XML 45 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6
8. FAIR VALUE MEASUREMENTS
3 Months Ended
Mar. 31, 2013
Fair Value Measurements  
8. FAIR VALUE MEASUREMENTS.

The fair value hierarchy prioritizes the inputs used in valuation techniques into three levels as follows:

·Level 1 – Observable inputs – unadjusted quoted prices in active markets for identical assets and liabilities;
·Level 2 – Observable inputs other than quoted prices included in Level 1 that are observable for the asset or liability through corroboration with market data; and
·Level 3 – Unobservable inputs – includes amounts derived from valuation models where one or more significant inputs are unobservable. For fair value measurements using significant unobservable inputs, a description of the inputs and the information used to develop the inputs is required along with a reconciliation of Level 3 values from the prior reporting period.

 

The Company recorded its warrants issued from 2010 through 2013 at fair value and designated them as Level 3 on their issuance dates.

Warrants – Except for the warrants issued September 26, 2012, the warrants were valued using a Monte Carlo Binomial Lattice-Based valuation methodology, adjusted for marketability restrictions. The warrants issued September 26, 2012, did not contain any anti-dilution protection features. As a result, the warrants were valued using the Black-Scholes Valuation Model. Of the various inputs used, the volatility and the current price of the Company’s common stock most significantly impact the fair value adjustments of the warrants. As the Company’s common stock increases or decreases, the valuation of the warrants will increase or decrease, respectively. As the estimated volatility of the Company’s common stock increases or decreases, the valuation of the warrants will increase or decrease, respectively. These changes may result in significantly higher or lower fair value measurements from period to period.

Significant assumptions used and related fair values for the warrants as of March 31, 2013 were as follows:

 

Original Issuance  Exercise Price   Volatility   Risk-Free Interest Rate   Term (years)   Discount for Marketability restrictions   Warrants Outstanding   Fair Value 
03/28/2013  $7.80    71.1%    0.24%    2.00    38.2%    788,000   $882,000 
01/11/2013  $7.80    72.5%    0.77%    4.79    54.4%    1,709,000    2,728,000 
09/26/2012  $8.85    84.2%    0.31%    2.49    75.9%    1,771,000    776,000 
07/3/2012  $7.50    71.1%    0.57%    4.26    51.8%    1,812,000    2,880,000 
07/3/2012  $6.45    63.7%    0.14%    0.76    57.6%    804,000    335,000 
12/13/2011  $11.25    68.1%    0.57%    3.71    47.1%    306,000    478,000 
                                 $8,079,000 

 

Significant assumptions used and related fair values for the warrants as of December 31, 2012 were as follows:

 

Original Issuance  Exercise Price   Volatility   Risk-Free Interest Rate   Term (years)   Discount for Marketability restrictions   Warrants Outstanding   Fair Value 
09/26/2012  $8.85    70.2%    0.36%    2.74    53.9%    1,833,000   $1,112,000 
07/3/2012  $7.50    76.1%    0.72%    4.51    55.5%    1,867,000    2,756,000 
07/3/2012  $6.45    69.3%    0.16%    1.01    55.5%    930,000    509,000 
12/13/2011  $12.45    74.4%    0.54%    3.95    52.3%    330,000    480,000 
10/6/2010  $1.80    76.0%    0.72%    4.80    46.4%    17,000    35,000 
                                 $4,892,000 

Convertible Notes – The conversion feature imbedded in the convertible notes was valued using a combination of a Monte Carlo Binomial Lattice-Based valuation methodology, adjusted for marketability restrictions. Significant assumptions used and related fair value for the conversion feature as of March 31, 2013 were as follows:

 

Original Issuance  Conversion Price   Volatility   Risk-Free Interest Rate   Term (years)   Market Discount   Fair Value 
3/28/13  $15.00    62.2%    0.14%    1.0    24.5%   $1,400,800 

Other Derivative Instruments – The Company’s other derivative instruments consist of commodity positions. The fair value of the commodity positions are based on quoted prices on the commodity exchanges and are designated as Level 1.

The following table summarizes fair value measurements by level at March 31, 2013 (in thousands):

 

   Level 1   Level 2   Level 3   Total 
Assets:                    
Commodity contracts(1)  $205   $   $   $205 
Total Assets  $205   $   $   $205 
                     
Liabilities:                    
Warrants(2)  $   $   $8,079   $8,079 
Conversion feature(2)           1,401    1,401 
Commodity contracts(3)   115            115 
Total Liabilities  $115   $   $9,480   $9,595 

 

(1) Included in other current assets in the consolidated balance sheets.

(2) Included in warrant liabilities and conversion feature at fair value in the consolidated balance sheets.

(3) Included in accrued liabilities in the consolidated balance sheets.

 

The following table summarizes fair value measurements by level at December 31, 2012 (in thousands):

   Level 1   Level 2   Level 3   Total 
Assets:                    
Commodity contracts(1)  $189   $   $   $189 
Total Assets  $189   $   $   $189 
                     
Liabilities:                    
Warrants  $   $   $4,892   $4,892 
Commodity contracts(2)   167            167 
Total Liabilities  $167   $   $4,892   $5,059 

 

(1) Included in other current assets in the consolidated balance sheets.

(2) Included in accrued liabilities in the consolidated balance sheets.

For fair value measurements using significant unobservable inputs (Level 3), a description of the inputs and the information used to develop the inputs is required along with a reconciliation of Level 3 values from the prior reporting period. The changes in the Company’s fair value of its Level 3 inputs were as follows (in thousands):

   Warrants   Conversion Feature 
Balance, December 31, 2012  $4,892   $ 
Issuance of warrants in January offering   2,657     
Issuance of notes and warrants in March offering   883    1,401 
Exercises of warrants   (260)    
Adjustments to fair value for the period   (93)    
Balance, March 31, 2013  $8,079   $1,401